Companies · Healthtech

Inspire Medical Systems, Inc.

MAPLE GROVE · Healthtech · refined from filed group “Other Health Care

Diligence memoA one-page analyst read on Inspire Medical Systems, Inc. — recommendation, valuation, rhythm, risks.
$52.5M
Total raised · real
2
Rounds
0.3×
Latest step-up
Top 10%
Sector rank · raised
Series B
Latest stage · inferred · Tue Oct 25 2016 00:00:00 GMT+0000 (Coordinated Universal Time)

Inspire Medical Systems, Inc. looks under-valued against its niche peers and is dormant on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the healthtech sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Under-valued
  • Modeled value is 0.59× the median modeled value of Series B Healthtech companies in 2016–2018 (33 peers) — value vs value, same stage and era.
Dormant
  • Last raise 9.7 yr ago; this sector typically re-raises about every 14 months.
  • Silent for over 3× the sector's normal cadence.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Healthtech

Inspire Medical Systems, Inc. is one of 2138 Healthtech companies tracked from MAPLE GROVE. By capital raised it ranks among the largest (ahead of 91% of sector peers), and among the largest by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Rule 506(b)
Reg D exemption
22
Investors (latest)
2016-10-25
First sale
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$250M$500M$750M$1.0BSeries B · 2014-03-28 Raised $40M (real) Modeled valuation $991M (est)$40M$991MSeries B2014Series B · 2016-10-25 Raised $13M (real) Modeled valuation $310M (est)$13M$310MSeries B2016+$13MCumulative $52M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Series B$40.0M · 2014
Series B extension$12.5M · 2016

Stages are modeled from round size (public records carry no series label). No record for: Pre-Seed, Seed, Series A — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 25%.

Modeled valuation trajectory
$309.8M
Base estimate est.
$29.4M
Conservative case
$1.2B
Upside case
$69.4M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Series Ba $15M–$40M round). Valuation is modeled from stage benchmarks scaled by the healthtech sector profile. Directional, not a quoted figure.

Series B · modeled $991.3M · 2014-03-282014Series B · modeled $309.8M · 2016-10-252016
Model inputs · modeled:benchmark-stage-stepup-v1
18%
Dilution assumption
Implied ownership sold in the financing.
64%
Survival probability
42% low · 78% high
1.38×/yr
Annual markup
1.67×/yr upside case
6.0 yr
Elapsed time used
9.7 yr actual, capped for stale marks
healthtech
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
31 mo
Avg between rounds
$20.4M/yr
Capital velocity
12.3 yr
On record since
2014
First round
2
Rounds on file
How it compares to the market

Benchmarked against 2138 companies in Healthtech. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 12× above median
This company$52.5M
Sector median$4.5M
Latest round — vs other Series B rounds in sector (real $, this stage) 0.7× of median
This company$12.5M
Sector median$18.3M
Modeled value — vs sector median (estimate, all stages) 9.2× above median
This company$309.8M
Sector median$33.8M

Raised more than 91% of sector peers (real $). Modeled value above 90% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Series B) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #27 of 33.

This companyCohort peer
$100.0M$1.0B$10.0B$10.0M$100.0MCapital raised (log)Altimate Medical Holdings, Inc. · Series B Raised $40.0M · modeled $991.3M (est)Southeast Healthcare Partners II, LLC · Series B Raised $34.0M · modeled $842.6M (est)NRS Health & Wellness GP LLC · Series B Raised $32.8M · modeled $813.0M (est)Aspire Health, Inc. · Series B Raised $49.9M · modeled $776.9M (est)Uprising Health LLC · Series B Raised $30.5M · modeled $756.9M (est)OODA Health, Inc. · Series B Raised $30.5M · modeled $755.9M (est)Provision Healthcare, LLC · Series B Raised $30.4M · modeled $752.2M (est)Limelight Health, Inc. · Series B Raised $40.2M · modeled $743.5M (est)Cc Dental Implants Holding, Llc · Series B Raised $27.0M · modeled $669.6M (est)Inari Medical, Inc. · Series B Raised $51.9M · modeled $669.2M (est)HealthReveal, Inc. · Series B Raised $26.6M · modeled $659.2M (est)Global Wellness International, Inc. · Series B Raised $25.0M · modeled $619.6M (est)Inspire Medical Systems, Inc. (this company) Raised $52.5M · modeled $309.8M (est)Inspire Medical Systems, Inc.
CompanyStageRaised · realValue · estvs peer med.
Altimate Medical Holdings, Inc.Series B$40.0M$991.3M1.89×
Southeast Healthcare Partners II, LLCSeries B$34.0M$842.6M1.60×
NRS Health & Wellness GP LLCSeries B$32.8M$813.0M1.55×
Aspire Health, Inc.Series B$49.9M$776.9M1.48×
Uprising Health LLCSeries B$30.5M$756.9M1.44×
OODA Health, Inc.Series B$30.5M$755.9M1.44×
Provision Healthcare, LLCSeries B$30.4M$752.2M1.43×
Limelight Health, Inc.Series B$40.2M$743.5M1.41×
Cc Dental Implants Holding, LlcSeries B$27.0M$669.6M1.27×
Inari Medical, Inc.Series B$51.9M$669.2M1.27×
HealthReveal, Inc.Series B$26.6M$659.2M1.25×
Global Wellness International, Inc.Series B$25.0M$619.6M1.18×
Inspire Medical Systems, Inc. this companySeries B$52.5M$309.8M0.59×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Series B$40.0M2014-03-28$222.2M$991.3M85%
Series B$12.5M2016-10-25$69.4M$309.8M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Series B$40.0M2014-03-28
    • First recorded raise — entered as Series B.
    • 13 investors on this round.
  2. Series B$12.5M2016-10-25
    • Raised again after 31 mo — slower than the ~14 mo sector norm.
    • Round 3.2× smaller than the prior — bridge or down round.
    • 22 investors on this round.
Intelligence
2019 ~Q2
Modeled next raise · ~31mo cadence
$12.5M
Modeled next size est.range $12.5M$20.0M
0.3×
Last step-up
$20.4M/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
Casey Tansey13 other2014-03
Chau Khuong8 other2014-03
Joyce Erony7 other2016-10
Dana Mead6 other2016-10
Benjamin Pless4 other2014-03
Mudit Jain3 other2014-03
GLEN NELSON2 other2014-03
Jerry Griffin2 other2014-03
Mark Fletcher2 other2014-03
Edward Shuck2014-03
Gary Brothers2016-10
Marilyn Nelson2016-10
Timothy Herbert2014-03
Registry & provenance

Inspire Medical Systems, Inc. is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1609550
SEC CIK
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
Noctrix Health, Inc.HealthtechSeries B$16.9M$354.6Mnetwork2 shared operators · same sector · same stage
XII Medical, Inc.HealthtechSeries B$45.1M$146.1Mnetwork1 shared operator · same sector · same stage
Contego Medical IncHealthtechSeries B$63.7M$235.0Mnetwork1 shared operator · same sector · same stage
ShiraTronics, IncBiotechnologySeries C$79.1M$307.5Mnetwork3 shared operators
Clinicient, IncHealthtechSeries B$52.1M$427.6Msame sector · same stage
Heartbeat Health, Inc.HealthtechSeries B$53.0M$164.7Msame sector · same stage
Wright Medical Group N.V.HealthtechSeries B$50.6M$386.6Msame sector · same stage
Integrated Care Partners, Inc.HealthtechSeries B$55.0M$145.9Msame sector · same stage
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
All Inspire Health, Inc.HealthtechSeries C$550.2M91%
Inspire Care 360, Inc.HealthtechPre-Seed$10.3M89%
InspireMD, Inc.Other Health CareSeries C$248.3M88%
Impulse Medical, Inc.HealthtechPre-Seed$3.0M86%
Medical Creations, Inc.HealthtechSeries A$122.5M84%
Ascent Medical Management, Inc.HealthtechPre-Seed$6.0M84%
Applaud Medical, Inc.HealthtechSeries B$44.1M83%
Heartbeat Health, Inc.HealthtechSeries B$164.7M83%
Frequently asked
How much funding has Inspire Medical Systems, Inc. raised?
Inspire Medical Systems, Inc. has raised approximately $52.5M in disclosed capital across 2 recorded financing rounds, aggregated from public filings.
What is Inspire Medical Systems, Inc.'s estimated valuation?
Provath's modeled valuation for Inspire Medical Systems, Inc. is approximately $309.8M (modeled range $29.4M–$1.2B). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is Inspire Medical Systems, Inc. at?
Inspire Medical Systems, Inc.'s latest modeled financing stage is Series B. Its most recent recorded round closed around Tue Oct 25.
What does Inspire Medical Systems, Inc. do and where is it based?
Inspire Medical Systems, Inc. operates in the Healthtech sector, based in MAPLE GROVE.
Explore related

See where Inspire Medical Systems, Inc. sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at Inspire Medical Systems, Inc., claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.